Jan Boren, Sweden
TBA TBA
Moderator of 2 Sessions
Session Time
15:30 - 17:00
Session Evaluation
Please click here to evaluate your knowledge. Your input is appreciated!
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1579,"presentation":"Introduction","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France","photo":""},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Philippe Moulin - EAS20 - 1579 - Introduction.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Philippe Moulin - EAS20 - 1579 - Introduction.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/28548063.jpg","data":[],"tracks":[]}]},{"name":"TG-rich lipoproteins as a risk factor","mode":"playlist","public":true,"info":{"id":1511,"presentation":"TG-rich lipoproteins as a risk factor","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Ruth Frikke-Schmidt, Denmark","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/619.jpg"},"playlist":[{"name":"TG-rich lipoproteins as a risk factor","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/EAS 1511 .mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/EAS 1511 .mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/F4BEE98F.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/EAS 1511 .vtt"}]},{"name":"The value of omega 3: from biology to clinical practice","mode":"playlist","public":true,"info":{"id":1512,"presentation":"The value of omega 3: from biology to clinical practice","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Alberto Zambon, Italy","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/550.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Alberto Zambon - EAS 2020 - 1512 - The value of omega 3 from biology to clinical practice.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Alberto Zambon - EAS 2020 - 1512 - The value of omega 3 from biology to clinical practice.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/6614D78C.jpg","data":[],"tracks":[]}]},{"name":"Position of omega 3 in Guidelines (as second choice after statins)","mode":"playlist","public":true,"info":{"id":1513,"presentation":"Position of omega 3 in Guidelines (as second choice after statins)","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Christie Ballantyne, United States of America","photo":""},"playlist":[{"name":"Position of omega 3 in Guidelines (as second choice after statins","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Christie M. Ballantyne MD EAS20 1513 Position of omega 3 in Guidelines (as second choice after statins.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Christie M. Ballantyne MD EAS20 1513 Position of omega 3 in Guidelines (as second choice after statins.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/63228A2.jpg","data":[],"tracks":[]}]},{"name":"Case: Diabetic patient with MI - how to manage?","mode":"playlist","public":true,"info":{"id":1514,"presentation":"Case: Diabetic patient with MI - how to manage?","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Dirk M\u00fcller-Wieland, Germany","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Dirk M\u00fcller-Wieland - EAS20 - 1514 - Case Diabetic patient with MI - how to manage.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Dirk M\u00fcller-Wieland - EAS20 - 1514 - Case Diabetic patient with MI - how to manage.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/8AC98309.jpg","data":[],"tracks":[]}]},{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1536,"presentation":"Panel Discussion with Live Q&A","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France, Jan Boren, Sweden, Ruth Frikke-Schmidt, Denmark, Alberto Zambon, Italy, Christie Ballantyne, United States of America, Dirk M\u00fcller-Wieland, Germany","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/619.jpg"},"playlist":[{"name":"The role of TG-rich lipoproteins in atherosclerosis","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/AA505DC4.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"9E32Xi02R"}
[session]
[presentation]
[presenter]
Session Time
12:00 - 13:00
Session Evaluation
Option 1
[{"name":"Repression of MAP1LC3A during atherosclerosis progression plays an important role in the regulation of vascular smooth muscle cell phenotype","mode":"playlist","public":true,"info":{"id":554,"presentation":"Repression of MAP1LC3A during atherosclerosis progression plays an important role in the regulation of vascular smooth muscle cell phenotype","session":"Rapid fire Session #1- Pathogenesis of Atherosclerosis","presenter":"Ewa Ehrenborg, Sweden","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/Ewa Ehrenborg - EAS2020 - 554 - Repression of MAP1LC3A during atherosclerosis progression plays an important role in the regulation of vascular smooth muscle cell.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/158\/Ewa Ehrenborg - EAS2020 - 554 - Repression of MAP1LC3A during atherosclerosis progression plays an important role in the regulation of vascular smooth muscle cell.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/1F4BD42B.jpg","data":[],"tracks":[]}]},{"name":"Bone marrow Deficiency in Melanocortin-1 Receptor Enhances Leukocytosis in ApoE-\/- Atherosclerotic Mice","mode":"playlist","public":true,"info":{"id":936,"presentation":"Bone marrow Deficiency in Melanocortin-1 Receptor Enhances Leukocytosis in ApoE-\/- Atherosclerotic Mice","session":"Rapid fire Session #1- Pathogenesis of Atherosclerosis","presenter":"James Kadiri, Finland","photo":""},"playlist":[{"name":"Bone marrow Deficiency in Melanocortin-1 Receptor Enhances Leukocytosis in ApoE-\/- Atherosclerotic M","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/P936.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/158\/P936.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/4B1D603D.jpg","data":[],"tracks":[]}]},{"name":"In vivo based biomechanics of the left main coronary bifurcation region","mode":"playlist","public":true,"info":{"id":518,"presentation":"In vivo based biomechanics of the left main coronary bifurcation region","session":"Rapid fire Session #1- Pathogenesis of Atherosclerosis","presenter":"Harry J. Carpenter, Australia","photo":""},"playlist":[{"name":"Harry Carpenter - EAS20 - ID518 - In vivo based biomechanics of the left main coronary bifurcation r","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/518.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/158\/518.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/3D7F7F75.jpg","data":[],"tracks":[]}]},{"name":"Single Cell transcriptomic analysis of aorta in diabetes associated atherosclerosis","mode":"playlist","public":true,"info":{"id":428,"presentation":"Single Cell transcriptomic analysis of aorta in diabetes associated atherosclerosis","session":"Rapid fire Session #1- Pathogenesis of Atherosclerosis","presenter":"Abdul Waheed Khan, Australia","photo":""},"playlist":[{"name":"Abdul Waheed Khan - EAS20 - 428 - Single Cell transcriptomic analysis of aorta in diabetes associate","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/Abdul Waheed Khan - EAS20 - 428 - Single Cell transcriptomic analysis of aorta in diabetes associated atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/158\/Abdul Waheed Khan - EAS20 - 428 - Single Cell transcriptomic analysis of aorta in diabetes associated atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/5A49C4.jpg","data":[],"tracks":[]}]},{"name":"Live Q&A","mode":"playlist","public":true,"info":{"id":1676,"presentation":"Live Q&A","session":"Rapid fire Session #1- Pathogenesis of Atherosclerosis","presenter":"Jan Boren, Sweden, Ewa Ehrenborg, Sweden, James Kadiri, Finland, Harry J. Carpenter, Australia, Abdul Waheed Khan, Australia","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/EAS20 Rapid fire Session 1.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/158\/EAS20 Rapid fire Session 1.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/B4728488.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"aE32Xi03J"}
[session]
[presentation]
[presenter]
Presenter of 2 Presentations
Live Q&A
Session Time
12:00 - 13:00
Lecture Time
12:20 - 12:50
[{"name":"Live Q&A","mode":"playlist","public":true,"info":{"id":1676,"presentation":"Live Q&A","session":"Rapid fire Session #1- Pathogenesis of Atherosclerosis","presenter":"Jan Boren, Sweden, Ewa Ehrenborg, Sweden, James Kadiri, Finland, Harry J. Carpenter, Australia, Abdul Waheed Khan, Australia","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/EAS20 Rapid fire Session 1.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/158\/EAS20 Rapid fire Session 1.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/158\/B4728488.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0uU"}
[session]
[presentation]
[presenter]
Panel Discussion with Live Q&A
Session Time
15:30 - 17:00
Lecture Time
16:29 - 16:44
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1536,"presentation":"Panel Discussion with Live Q&A","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France, Jan Boren, Sweden, Ruth Frikke-Schmidt, Denmark, Alberto Zambon, Italy, Christie Ballantyne, United States of America, Dirk M\u00fcller-Wieland, Germany","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/619.jpg"},"playlist":[{"name":"The role of TG-rich lipoproteins in atherosclerosis","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/AA505DC4.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0su"}
[session]
[presentation]
[presenter]
